High Tide Inc. HITI

Updated: 11 Aug 2026

NASDAQ | Retail | Cannabis retail and medical distribution

No signal published yet

We already track High Tide and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow High Tide free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Retail
Sector
Cannabis retail and medical distribution
We're already tracking High Tide Inc. — here are the latest events we've registered

Recent News

  • On August 4, 2026, High Tide issued preliminary guidance for its third fiscal quarter ended July 31, 2026, projecting revenue between C$195.0 million and C$200.0 million. The company also announced that its German subsidiary, Remexian Pharma GmbH, distributed over 10 tonnes of medical cannabis flower during the quarter. Full Q3 results are scheduled to be released on September 14, 2026.

What Firelda Watch includes for High Tide Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of High Tide Inc. will be delivered in the same format.

Want to follow High Tide Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow High Tide free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

High Tide Inc. HITI
High Tide — follow and we'll monitor it
Follow High Tide free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.